Coverage
-
March 16, 2017
AstraZeneca AB and Zydus Pharmaceuticals USA Inc., an American subsidiary of Indian drugmaker Zydus Cadila, have settled a New Jersey federal lawsuit alleging that Zydus' plans to manufacture generic versions of Nexium infringe AstraZeneca's patents on the heartburn drug.
1 other articles on this case.
View all »